Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Vilma, Sniukiene"'
Autor:
Lee P. Shulman, Yifan Mo, David E. Soper, Andrea S. Lukes, Vilma Sniukiene, Amanda Harrington, Patrick Gillard
Publikováno v:
Obstetrics and Gynecology
Ulipristal acetate is associated with significant improvements in health-related quality of life and symptom severity compared with placebo in women with symptomatic uterine leiomyomas.
OBJECTIVE: To investigate effects of ulipristal acetate on
OBJECTIVE: To investigate effects of ulipristal acetate on
Autor:
Ayman Al-Hendy, Rick Blakesley, Anna Chan, Vilma Sniukiene, William H. Catherino, James H. Segars, James A. Simon
Publikováno v:
Obstet Gynecol
OBJECTIVE: To assess efficacy and tolerability of ulipristal acetate, a selective progesterone receptor modulator, for treatment of symptomatic uterine leiomyomas. METHODS: This phase 3, double-blind, placebo-controlled study enrolled premenopausal w
Publikováno v:
Menopause (New York, N.y.)
Objective: Vulvovaginal atrophy (VVA) is characterized by vaginal changes, dyspareunia, and itching/irritation. Efficacy and safety of a lower-dose estradiol vaginal cream (0.003%) were evaluated in postmenopausal women with VVA-related dyspareunia.
Publikováno v:
Journal of drugs in dermatology : JDD. 17(3)
There is a need for new oral antibiotics for acne with improved safety profiles and targeted antibacterial spectra. Sarecycline is a novel, tetracycline-class antibiotic specifically designed for acne, offering a narrow spectrum of activity compared
Autor:
Rick Blakesley, Carol C. Eisenhut, Steven R. Goldstein, Anna Chan, Donald Ian Smith, Vilma Sniukiene, William H. Catherino
Publikováno v:
American Journal of Clinical Pathology. 149:S22-S23
Autor:
Vilma Sniukiene, Ayman Al-Hendy, Anna Chan, Rick Blakesley, William H. Catherino, James A. Simon
Publikováno v:
Obstetrics & Gynecology. 129:78S-79S
Autor:
Donald Ian Smith, Vilma Sniukiene, Madhuja Mallick, Carol C. Eisenhut, Steven R. Goldstein, Anna Chan
Publikováno v:
American Journal of Clinical Pathology. 150:S74-S74
Publikováno v:
Obstetrics & Gynecology. 131:187S-187S
Autor:
Henry Pollack, Thomas Lang, Norberto Rodriguez-Baez, Teresita Gonzalez, Janice K. Albrecht, Clifford A. Brass, Estella M. Alonso, Alain Lachaux, Stephanie Noviello, Marcela Galoppo, Wolf Deitrich Huber, F. Lacaille, Maria Angeles Calzado, Vilma Sniukiene, Nanda Kerkar, Jyoti Ramakrishna, Stefan Wirth, Antonio Del Valle-Segarra, Alejandra Pedreira, Mirta Ciocca, Flavia Bortolotti, Christine Xu, M Shelton, Carmen Ribes-Koninckx, Paloma Jara, Deborah A. Neigut, Lucia Zancan, Zachery Goodman, Hanzhe Zheng, Bessie Hunter, Ulrike Kullmer, Pierre Broué
Publikováno v:
Journal of Hepatology. 52:501-507
Pegylated interferon (PEG-IFN) alfa-2b plus ribavirin (RBV) is the standard of care for adults with chronic hepatitis C but was not approved for the treatment of children at the time of this study. The aim of this study was to evaluate the efficacy a
Autor:
W. Deng, Bruce R. Bacon, Eric Lawitz, Margaret Burroughs, Stuart C Gordon, M. Davis, Jean-Pierre Bronowicki, Fred Poordad, Clifford A. Brass, Mark S. Sulkowski, Frank J. Dutko, Vilma Sniukiene, Eric M. Yoshida, Janice K. Albrecht, Rafael Esteban, K. Rajender Reddy
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2013, 38 (1), pp.16-27. ⟨10.1111/apt.12342⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2013, 38 (1), pp.16-27. ⟨10.1111/apt.12342⟩
International audience; BACKGROUND:Adherence to therapeutic regimens affects the efficacy of peginterferon alfa (P) and ribavirin (R) therapy in patients with chronic hepatitis C virus genotype 1.AIM:To determine if medication adherence impacts effic